Trial Profile
A prospective randomly controlled clinical study to evaluate azithromycin therapy for treatment of children with nephrotic syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2015
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary) ; Prednisone
- Indications Nephrotic syndrome
- Focus Therapeutic Use
- 20 Nov 2015 Status changed from not stated to completed.
- 20 Nov 2015 New trial record